Allogene Therapeutics Company

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Technology: CAR-T
Industry: CAR-T
Headquarters: South San Francisco, California, United States
Founded Date: 2017-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 14
Total Funding: 531770409
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-09-07
Last Funding Type: Convertible Note

Visit Website
Register and Claim Ownership